Tamil Nadu, India

Ponnusamy Baskaran

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Univerzita Palackeho V Olomouci. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ponnusamy Baskaran. Retrieved from https://idiyas.com/inventor/ponnusamy-baskaran

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ponnusamy Baskaran: Innovator in Glycosylpurines

Introduction

Ponnusamy Baskaran is a notable inventor based in Tamil Nadu, India. He has made significant contributions to the field of pharmaceuticals through his innovative research and development.

Latest Patents

Baskaran holds a patent for "6-aryl-9-glycosylpurines and use thereof." This patent includes 6-aryl-9-glycosidpurines of general formula I and pharmaceutically acceptable salts thereof with alkali metals, ammonia, amines, or addition salts with acids. His work in this area demonstrates his commitment to advancing pharmaceutical science.

Career Highlights

Baskaran is affiliated with Palacký University Olomouc, where he continues to engage in research and development. His academic background and professional experience have positioned him as a key figure in his field.

Collaborations

Some of his notable coworkers include Karel Dolezal and Johannes Van Staden. Their collaborative efforts contribute to the advancement of research in glycosylpurines.

Conclusion

Ponnusamy Baskaran's innovative work in the field of glycosylpurines highlights his dedication to pharmaceutical advancements. His contributions are valuable to both academia and industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…